Cell Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Cell Therapeutics Inc
TickerCTIC
CIK #0000891293
CUSIP12648L601
SectorLife Sciences - Pharmaceutical Preparations
Address501 Elliott Ave W Ste 400, Seattle, WA 98119
Source [EDGAR]
CIK Filing 2011 - 2024
[0000891293] 10-K
[0000891293] 10-Q
[0000891293] 3
[0000891293] 4
[0000891293] 5
[0000891293] 8-K
[0000891293] SC 13D
[0000891293] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Stonepine Capital Management LLC CTI Biopharma Corp [2023-04-13] 5.3
Lynch Timothy P CTI Biopharma Corp [2023-03-24] 5.3
BlackRock Inc CTI Biopharma Corp [2023-02-03] 5.6
State Street Corp CTI Biopharma Corp [2022-10-11] 12.01
Millennium Management LLC CTI Biopharma Corp [2022-06-13] 5.5
Caxton Corp CTI Biopharma Corp [2020-10-02] 6.1
Growth Equity Opportunities V LLC CTI Biopharma Corp [2018-02-20] 6.0
Stonepine Capital Management LLC CTI Biopharma Corp [2017-06-22] 7.6
OrbiMed Advisors LLC CTI Biopharma Corp [2017-06-15] 11.6
Baxalta Inc CTI Biopharma Corp [2016-02-12] 14.8
NB Public Equity K/S CTI Biopharma Corp [2016-01-29] 5.5
BlackRock Inc CTI Biopharma Corp [2016-01-28] 5.1
Biotechnology Value Fund L P CTI Biopharma Corp [2015-12-11] 5.3
FMR LLC CTI Biopharma Corp [2015-11-10] 0.0
Biotechnology Value Fund L P CTI Biopharma Corp [2015-10-02] 2.6
Baxalta Inc CTI Biopharma Corp [2015-05-01] 8.7
Eagle Asset Management Inc CTI Biopharma Corp [2015-01-07] 7.2
BlackRock Inc Cell Therapeutics Inc [2014-01-28] 5.9
Baxter International Inc Cell Therapeutics Inc [2013-11-25] 10.8
FMR LLC Cell Therapeutics Inc [2012-11-13] 0.0
Tang Capital Partners LP Cell Therapeutics Inc [2012-10-09] 9.9
Socius Capital Group LLC Cell Therapeutics Inc [2012-06-04] 9.9
BlackRock Inc Cell Therapeutics Inc [2012-02-09] 5.39
Form 3/4/5 Filer 2011 - 2024
Perry Matthew D
CTI Biopharma Corp
Lampert Mark N
Biotechnology Value Trading Fund OS LP
BVF GP Holdings LLC
BVF II GP LLC
Biotechnology Value Fund II LP
BVF Partners OS Ltd.
BVF Inc/IL
BVF Partners L P/IL
BVF I GP LLC
Biotechnology Value Fund L P
Parkinson David Ross
Metzger Michael A
Parks Diane L.
Tuckson Reed Vaughn
Fischer Laurent
Craig Adam R
Fong James K
Kirske David
Seeley Bruce J
OrbiMed Advisors LLC
OrbiMed Capital GP VI LLC
Telling Fred
Singer Jack W
Love Richard L
Isaly Samuel D
Nudelman Phillip M PhD
Bianco James A
Mundinger Mary ONeil
Bianco Louis A
Plunkett Matthew
Ignagni Karen
Bauer John H
Baxter Healthcare SA
Gregorian Vartan
Baxter International Inc
Benner Steven E
Philips Craig W
Eramian Daniel G
Form 13F Holdings
Firm Period DFND Voting Shares
State Street Corp [2023-03-31] DFND 12,269,818.0 12,437,278.0
Rubric Capital Management LP [2023-03-31] SOLE 8,963,256.0 8,963,256.0
BVF Inc/IL [2023-03-31] DFND 0.0 8,813,021.0
BlackRock Inc. [2023-03-31] SOLE 6,917,561.0 7,102,626.0
Stonepine Capital Management LLC [2023-03-31] SOLE 6,535,674.0 6,535,674.0
Marshall Wace LLP [2023-03-31] OTR 0.0 5,960,103.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 5,776,698.0
Bain Capital Life Sciences Investors, LLC [2023-03-31] SOLE 4,702,996.0 4,702,996.0
Bleichroeder LP [2023-03-31] SOLE 3,893,730.0 3,893,730.0
NEA Management Company LLC [2023-03-31] DFND 3,685,683.0 3,685,683.0
Bank of America Corp /DE/ [2023-03-31] DFND 20,323.0 3,510,679.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 3,021,558.0
Sofinnova Investments Inc [2023-03-31] SOLE 2,794,542.0 2,794,542.0
Geode Capital Management LLC [2023-03-31] DFND 2,029,780.0 2,029,780.0
Ghost Tree Capital LLC [2023-03-31] SOLE 2,000,000.0 2,000,000.0
Schonfeld Strategic Advisors LLC [2023-03-31] SOLE 1,953,712.0 1,953,712.0
Verition Fund Management LLC [2023-03-31] SOLE 1,932,153.0 1,932,153.0
Parkman Healthcare Partners LLC [2023-03-31] SOLE 1,753,630.0 1,753,630.0
AIGH Capital Management LLC [2023-03-31] SOLE 1,583,411.0 1,583,411.0
Ensign Peak Advisors, Inc [2023-03-31] SOLE 1,326,062.0 1,326,062.0
Susquehanna International Group LLP [2023-03-31] DFND 813,905.0 1,289,605.0
Sectoral Asset Management Inc [2023-03-31] SOLE 518,300.0 1,253,300.0
Nuveen Asset Management LLC [2023-03-31] DFND 1,247,261.0 1,247,261.0
Goldman Sachs Group Inc [2023-03-31] DFND 1,153,631.0 1,183,198.0
Rafferty Asset Management LLC [2023-03-31] SOLE 1,136,381.0 1,136,381.0
JPMorgan Chase & Co [2023-03-31] DFND 918,972.0 1,124,714.0
J Goldman & Co LP [2023-03-31] SOLE 1,091,384.0 1,091,384.0
ExodusPoint Capital Management LP [2023-03-31] OTR 0.0 952,343.0
Citigroup Inc [2023-03-31] DFND 906,013.0 906,013.0
Millennium Management LLC [2023-03-31] SOLE 866,152.0 866,152.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com